12/06/2018

J-code J9312 will replace J9310 for RITUXAN and the billable units will change from 100 mg to 10 mg.

The Centers for Medicare & Medicaid Services (CMS) has made a change to the RITUXAN® (rituximab) J-code and has assigned a permanent J-code for RITUXAN HYCELA® (rituximab/hyaluronidase human subcutaneous injection). Effective January 1, 2019 J-code J9312 will replace J9310 for RITUXAN and the billable units will change from 100 mg to 10 mg. 

Additionally, the permanent J-code assigned for RITUXAN HYCELA is J9311. The RITUXAN AND RITUXAN HYCELA J-Code Flash Card, attached to this email, details the new J-code information. We encourage you to post this by your desk for quick reference and forward to your billing department. 

If you have any questions, call Genentech Access Solutions at (866) 681-3261 (Monday through Friday, 6 a.m. to 5 p.m. PT). You can also visit Genentech-Access.com.